506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT00003545 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: nelarabine

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]